(ind)

D and P Advisory Curates 'Beyond 22 Yards 'The Power of Platforms, The Price of Regulation' an IPL & WPL Valuation Report for the year 2025'

For the first time in its history, the IPL has faced two consecutive years of ecosystem valuation decline—from IND 92,500…

3 weeks ago

India Ratings Affirms Star Health Insurance Company’s Rating at ‘IND AA+’ with a Stable Outlook

CHENNAI, India, Oct. 1, 2025 /PRNewswire/ -- Star Health and Allied Insurance Company Limited (Star Health), India's leading standalone health…

1 month ago

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…

3 months ago

Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors

July 02, 2025 06:00 ET  | Source: Instil Bio US phase 1 trial of ‘2510 is expected to be initiated before…

4 months ago